Abacus Bioscience Inc

Infectious Disease Research Institute is a leading research facility based in Seattle, WA, specializing in the study and development of treatments for infectious diseases. With a team of dedicated scientists and researchers, the institute focuses on advancing knowledge and finding innovative solutions to combat a wide range of infectious diseases.Generated from their business information

Actx Inc, based in Seattle, WA, offers genomic services and personalized user experiences through their website. Users can access and use the services by accepting the terms of service, which outline legal rights and obligations. The company provides a non-exclusive license to access and use their materials, including data, software, and information, while also emphasizing the importance of privacy and feedback. Actx reserves the right to modify terms and conditions, requiring users to review and accept any changes to continue using their services.Generated from the website

Stemgenics is a Seattle-based company that specializes in disruptive nanotherapeutics technology, offering a multi-specific platform for therapeutic drug development. Their patent-protected non-integrating nanoparticles, known as NIMFA-NP, are designed to deliver a wide range of bioactive molecules into cells, tissues, organs, and organisms, making them highly effective in regenerative medicine, oncology, and vaccine development. With a focus on regenerative medicine, Stemgenics' customizable NIMFA-NP can be functionalized with different bioactive molecules to target specific intracellular processes, allowing for tissue rejuvenation, organ revitalization, and lifespan extension. Additionally, their nanotechnology, protected by numerous patents, enables in vivo direct reprogramming of cells for liver and heart regeneration, as well as the treatment of neurodegenerative diseases and oncology through gene-specific mRNA and siRNA therapeutics.Generated from the website